Hansen Medical, Inc. Sustainability Profile
Hansen Medical, Inc., a pioneering force in the medical robotics industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development of innovative robotic systems for catheter-based procedures, primarily focusing on electrophysiology and vascular interventions. Hansen Medical's flagship products, including the Magellan™ and Sensei™ robotic systems, are distinguished by their precision and enhanced control, significantly improving patient outcomes. The company has achieved notable milestones, including FDA approvals and successful clinical applications, solidifying its position in the market. With a commitment to advancing minimally invasive therapies, Hansen Medical continues to shape the future of healthcare through cutting-edge technology and exceptional service.
DitchCarbon Score
How does Hansen Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hansen Medical, Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hansen Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Johnson & Johnson, and as such, it inherits emissions data and climate commitments from its parent organisation. Hansen Medical's climate initiatives are aligned with those of Johnson & Johnson, which has set ambitious targets for reducing carbon emissions across its operations. These targets are cascaded down to Hansen Medical, reflecting a commitment to sustainability and climate action. However, specific reduction targets or achievements for Hansen Medical itself have not been disclosed. The emissions data and climate strategies are sourced from Johnson & Johnson, which participates in various initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and RE100, all at a cascade level of 2. This indicates that while Hansen Medical is committed to climate action, it relies on the broader corporate strategies of its parent company for specific guidance and metrics. In summary, while Hansen Medical, Inc. does not have its own emissions data or specific reduction targets, it is part of a larger corporate family that prioritises sustainability and has established frameworks for reducing carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Hansen Medical, Inc.'s Industry?
How Carbon Intensive is Hansen Medical, Inc.'s Location?
Hansen Medical, Inc.'s Scope 3 Categories Breakdown
Hansen Medical, Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Hansen Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hansen Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
